Literature DB >> 17671937

Phacoemulsification on previously vitrectomized eyes: results of a 10-year-period.

Z Szijarto1, B Haszonits, Z Biró, B Kovacs.   

Abstract

PURPOSE: To provide an overview of intraoperative and postoperative complications during phacoemulsification cataract surgery and to evaluate the visual results in patients having pars plana vitrectomy (PPV) with 10 years of follow-up.
METHODS: Retrospective evaluation of intraoperative and postoperative complications and postoperative visual results in 134 consecutive patients who underwent phacoemulsification after PPV. Of 11,498 eyes treated with phacoemulsification, 143 (1.2%) had previous PPV during the 10-year period were included in this study.
RESULTS: The phacoemulsification procedure seemed to be difficult where there was a deep or fluctuating anterior chamber (93%) and primary posterior capsule opacification (19%). The most frequent intraoperative complications were posterior capsule rupture (9%) and incomplete capsular rhexis (5%). Postoperative intraocular pressure elevation (7%), retinal detachment (6%), and posterior capsule opacification (8%) occurred most frequently during the mean follow-up period of 18.2 months (1.5-110 months). Best-corrected visual acuity (BCVA) increased two or more Snellen E lines in 55% of the cases or became better than or equal to 0.5 in 10% of the cases.
CONCLUSIONS: Despite the well-known difficulties encountered in vitrectomized eyes such as zonular damage, increased mobility of the lens-iris diaphragm, and altered intraocular fluid dynamics, phacoemulsification proved to be a safe procedure in the hands of experienced surgeons.

Entities:  

Mesh:

Year:  2007        PMID: 17671937     DOI: 10.1177/112067210701700419

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  9 in total

1.  20-gauge and 23-gauge phacovitrectomy for idiopathic macular holes: comparison of complications and long-term outcomes.

Authors:  R Krishnan; C Tossounis; Y Fung Yang
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

2.  A reasonable option in vitrectomized eyes: manual small incision cataract surgery.

Authors:  Hüseyin Bayramlar; Remzi Karadag; Bahri Aydin; Yaşar Dag
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

3.  Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice.

Authors:  B Gupta; R Wong; S Sivaprasad; T H Williamson
Journal:  Eye (Lond)       Date:  2012-01-13       Impact factor: 3.775

4.  Epiretinal membrane vitrectomy: outcomes with or without cataract surgery and a novel prognostic factor for cystoid macular edema.

Authors:  Nisa Silva; André Ferreira; João Heitor Marques; Natália Ferreira; Nuno Correia; Bernardete Pessoa; João Melo Beirão; Ferenc Kuhn; Angelina Meireles
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-25       Impact factor: 3.117

5.  Vitrectomy as a Risk Factor for Complicated Cataract Surgery.

Authors:  Moss J Fenberg; Kenneth J Hainsworth; Frank G Rieger; Dean P Hainsworth
Journal:  Mo Med       Date:  2016 Jan-Feb

6.  Comment on: Microincision phacoemulsification combined with sutureless transpupillary passive silicone oil removal.

Authors:  Sandip Sarkar; Amit K Deb
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 1.848

7.  Nd:YAG Capsulotomy after Phacoemulsification in Vitrectomized Eyes: Effects of Pars Plana Vitrectomy on Posterior Capsule Opacification.

Authors:  Jong Hwa Jun; Kwang Soo Kim; Sung Dong Chang
Journal:  J Ophthalmol       Date:  2014-04-27       Impact factor: 1.909

8.  Vitrectomy versus Phaco-vitrectomy.

Authors:  Ahmed Sulaiman Al-Hinai
Journal:  Oman J Ophthalmol       Date:  2019 May-Aug

9.  In Vivo Imaging of Intraocular Fluidics in Vitrectomized Swine Eyes Using a Digital Fluoroscopy System.

Authors:  Tamer Tandogan; Ramin Khoramnia; Gerd Uwe Auffarth; Michael Janusz Koss; Chul Young Choi
Journal:  J Ophthalmol       Date:  2016-04-03       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.